Market Overview

Brean Murray Carret & Co. Upgrades Vertex Pharmaceuticals from Hold to Buy, Announces PT of $69

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Brean Murray Carret & Co.Upgrades Price Target Initiation Analyst Ratings

 

Most Popular

Related Articles (VRTX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free